Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

BACKGROUND: Successful delivery of cell-based therapeutics into patients is compromised by their short shelf-life upon release from production facilities due to the living nature of the active component that rapidly loses viability, and therefore its properties. In this context, the use of appropria...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabel, Clémentine, Puente-Massaguer, Eduard, del Mazo-Barbara, Anna, Reyes, Blanca, Morton, Philip, Gòdia, Francesc, Vives, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201632/
https://www.ncbi.nlm.nih.gov/pubmed/30355298
http://dx.doi.org/10.1186/s12967-018-1659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201632/
https://www.ncbi.nlm.nih.gov/pubmed/30355298
http://dx.doi.org/10.1186/s12967-018-1659-4

Ejemplares similares